Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Simulated application of US cardiology guidelines for statin use to hospital patients in Turkey.

Rohrer JE, Doganer YC, Agerter DC, Aydogan U, Barcin C.

Qual Manag Health Care. 2014 Jul-Sep;23(3):163-8. doi: 10.1097/QMH.0000000000000037.

PMID:
24978165
2.
3.

The 2013 ACC/AHA cardiovascular prevention guidelines improve alignment of statin therapy with coronary atherosclerosis as detected by coronary computed tomography angiography.

Pursnani A, Mayrhofer T, Ferencik M, Hoffmann U.

Atherosclerosis. 2014 Nov;237(1):314-8. doi: 10.1016/j.atherosclerosis.2014.09.023. Epub 2014 Sep 30.

PMID:
25299966
4.

Does use of pooled cohort risk score overestimate the use of statin?: a retrospective cohort study in a primary care setting.

Chia YC, Lim HM, Ching SM.

BMC Fam Pract. 2014 Nov 12;15:172. doi: 10.1186/s12875-014-0172-y.

5.

Heterogeneity in statin indications within the 2013 american college of cardiology/american heart association guidelines.

Shah RV, Rubenfire M, Brook RD, Lima JA, Nallamothu B, Murthy VL.

Am J Cardiol. 2015 Jan 1;115(1):27-33. doi: 10.1016/j.amjcard.2014.09.045. Epub 2014 Oct 12.

PMID:
25456869
6.

Four out of ten patients are not taking statins regularly during the 12 months after an acute coronary event.

Thornley S, Marshall R, Chan WC, Kerr A, Harrison J, Jackson G, Crengle S, Wright C, Wells S, Jackson R.

Eur J Prev Cardiol. 2012 Jun;19(3):349-57. doi: 10.1177/1741826711403069. Epub 2011 Mar 14.

PMID:
21450568
7.
8.

Effect of time to titration to maximum dose of statins on cardiovascular outcomes: a retrospective analysis in high-risk patients.

Friend AS, Kamalesh M, Schellhase E, Eckert GJ, Evans TS.

Am J Cardiovasc Drugs. 2009;9(2):103-7. doi: 10.2165/00129784-200909020-00004.

PMID:
19331438
9.

Patterns of statin prescription in acute myocardial infarction: the French registry of Acute ST-elevation or non-ST-elevation Myocardial Infarction (FAST-MI).

Ferrières J, Bataille V, Leclercq F, Geslin P, Ruidavets JB, Grollier G, Bernard P, Cambou JP, Simon T, Danchin N.

Atherosclerosis. 2009 Jun;204(2):491-6. doi: 10.1016/j.atherosclerosis.2008.09.031. Epub 2008 Oct 8.

PMID:
19004441
10.

Cholesterol treatment and changes in guidelines in an academic medical practice.

Schoen MW, Salas J, Scherrer JF, Buckhold FR.

Am J Med. 2015 Apr;128(4):403-9. doi: 10.1016/j.amjmed.2014.10.039. Epub 2014 Nov 18.

PMID:
25460526
11.

Application of new cholesterol guidelines to a population-based sample.

Pencina MJ, Navar-Boggan AM, D'Agostino RB Sr, Williams K, Neely B, Sniderman AD, Peterson ED.

N Engl J Med. 2014 Apr 10;370(15):1422-31. doi: 10.1056/NEJMoa1315665. Epub 2014 Mar 19.

12.

Prehospital statin therapy and one-year mortality in patients with stable coronary artery disease undergoing percutaneous coronary intervention.

Ndrepepa G, King L, Cassese S, Fusaro M, Tada T, Schömig A, Kastrati A.

Eur J Intern Med. 2013 Mar;24(2):145-50. doi: 10.1016/j.ejim.2012.10.008. Epub 2012 Nov 20.

PMID:
23182629
13.

The impact of statin therapy on long-term cardiovascular outcomes in an outpatient cardiology practice.

Lai HM, Aronow WS, Mercando AD, Kalen P, Desai HD, Gandhi K, Sharma M, Amin H, Lai TM.

Med Sci Monit. 2011 Dec;17(12):CR683-6.

14.

Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice.

Bruckert E, Ferrières J.

Arch Cardiovasc Dis. 2014 Mar;107(3):188-200. doi: 10.1016/j.acvd.2014.01.011. Epub 2014 Mar 7.

15.

Optimizing statin treatment for primary prevention of coronary artery disease.

Hayward RA, Krumholz HM, Zulman DM, Timbie JW, Vijan S.

Ann Intern Med. 2010 Jan 19;152(2):69-77. doi: 10.7326/0003-4819-152-2-201001190-00004. Erratum in: Ann Intern Med. 2011 Jun 21;154(12):848.

PMID:
20083825
16.

Patterns and predictors of statin prescription in patients with type 2 diabetes.

Berthold HK, Gouni-Berthold I, Böhm M, Krone W, Bestehorn KP.

Cardiovasc Diabetol. 2009 May 13;8:25. doi: 10.1186/1475-2840-8-25.

17.

Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.

Heintjes EM, Penning-van Beest FJ, Plat AW, Meerding WJ, Webb K, Sturkenboom MC, Herings RM.

Pharmacotherapy. 2012 Jul;32(7):631-41. doi: 10.1002/j.1875-9114.2011.01086.x.

PMID:
22760692
18.

Cholesterol end points predict outcome in patients with coronary disease: quality improvement metrics from the enhancing secondary prevention in coronary artery disease (ESP-CAD) trial.

McAlister FA, Majumdar SR, Lin M, Bakal J, Fradette M, Anderson T.

Can J Cardiol. 2014 Dec;30(12):1627-32. doi: 10.1016/j.cjca.2014.07.008. Epub 2014 Jul 16.

PMID:
25307535
19.

Achieving vascular risk factor targets: a survey of a London general practice.

Levine AP, Mikhailidis DP, Moross T, Benson K, Gor M.

Angiology. 2008 Feb-Mar;59(1):36-46. doi: 10.1177/0003319707309538.

PMID:
18319220
20.

Comparing impact and cost-effectiveness of primary prevention strategies for lipid-lowering.

Pletcher MJ, Lazar L, Bibbins-Domingo K, Moran A, Rodondi N, Coxson P, Lightwood J, Williams L, Goldman L.

Ann Intern Med. 2009 Feb 17;150(4):243-54.

PMID:
19221376

Supplemental Content

Support Center